ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: You Angie
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Kunkel Lori Anne
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Heyman Richard A.
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Hoerter Steven L.
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Dier Mardi
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.